Sven Stadlbauer

411 total citations
26 papers, 289 citations indexed

About

Sven Stadlbauer is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Sven Stadlbauer has authored 26 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Sven Stadlbauer's work include Radiopharmaceutical Chemistry and Applications (17 papers), Boron Compounds in Chemistry (7 papers) and Peptidase Inhibition and Analysis (6 papers). Sven Stadlbauer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Boron Compounds in Chemistry (7 papers) and Peptidase Inhibition and Analysis (6 papers). Sven Stadlbauer collaborates with scholars based in Germany, Czechia and Slovakia. Sven Stadlbauer's co-authors include Evamarie Hey‐Hawkins, René Frank, Klaus Kopka, Peter Lönnecke, Peter Welzel, Annette G. Beck‐Sickinger, Cornelius K. Donat, Martin Ullrich, Barbara Kirchner and Matthias Eder and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Sven Stadlbauer

21 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Stadlbauer Germany 10 194 72 64 61 46 26 289
Lutz F. Schweiger United Kingdom 12 173 0.9× 77 1.1× 111 1.7× 75 1.2× 33 0.7× 21 436
Sabrina Niedermoser Germany 9 298 1.5× 150 2.1× 120 1.9× 63 1.0× 22 0.5× 16 447
Joshua Chin Canada 10 313 1.6× 132 1.8× 128 2.0× 96 1.6× 30 0.7× 12 429
Gemma Dias United Kingdom 11 194 1.0× 147 2.0× 116 1.8× 51 0.8× 26 0.6× 21 347
Kristina Westerlund Sweden 15 258 1.3× 121 1.7× 237 3.7× 82 1.3× 30 0.7× 27 478
Gonçalo S. Clemente United Kingdom 11 123 0.6× 66 0.9× 77 1.2× 39 0.6× 43 0.9× 17 351
Marie Brandt Austria 8 221 1.1× 80 1.1× 41 0.6× 30 0.5× 68 1.5× 16 312
Swarbhanu Sarkar India 14 131 0.7× 55 0.8× 110 1.7× 234 3.8× 78 1.7× 42 472
Robert Kuhnert Germany 9 365 1.9× 47 0.7× 75 1.2× 120 2.0× 129 2.8× 13 439
Paul Hoppenz Germany 8 163 0.8× 89 1.2× 236 3.7× 68 1.1× 72 1.6× 11 455

Countries citing papers authored by Sven Stadlbauer

Since Specialization
Citations

This map shows the geographic impact of Sven Stadlbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Stadlbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Stadlbauer more than expected).

Fields of papers citing papers by Sven Stadlbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Stadlbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Stadlbauer. The network helps show where Sven Stadlbauer may publish in the future.

Co-authorship network of co-authors of Sven Stadlbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Stadlbauer. A scholar is included among the top collaborators of Sven Stadlbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Stadlbauer. Sven Stadlbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franchi, Sara, Claudia Graiff, Ileana Menegazzo, et al.. (2025). Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based Chelators. Inorganic Chemistry. 64(45). 22422–22440.
2.
Wodtke, Robert, Kristof Zarschler, Markus Laube, et al.. (2025). In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals. 18(11). 1656–1656.
3.
Ullrich, Martin, Falco Reissig, Zbyněk Nový, et al.. (2025). It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 10(1). 31–31.
4.
Donat, Cornelius K., et al.. (2025). Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging. EJNMMI Radiopharmacy and Chemistry. 10(1). 77–77.
5.
Donat, Cornelius K., et al.. (2025). Structure–activity relationship of 18F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance. EJNMMI Radiopharmacy and Chemistry. 10(1). 33–33. 1 indexed citations
7.
Donat, Cornelius K., et al.. (2024). Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands. EJNMMI Radiopharmacy and Chemistry. 9(1). 14–14. 5 indexed citations
8.
Donat, Cornelius K., et al.. (2023). Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics. International Journal of Molecular Sciences. 24(20). 15088–15088. 2 indexed citations
9.
Donat, Cornelius K., Martin Ullrich, Kristof Zarschler, et al.. (2023). Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers. 15(9). 2638–2638. 20 indexed citations
10.
Laube, Markus, Martin Ullrich, Cornelius K. Donat, et al.. (2023). Preparation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [18F]Fluoride Exchange Reaction. Pharmaceutics. 15(12). 2749–2749. 8 indexed citations
11.
Brandt, Florian, Markus Laube, Martin Ullrich, et al.. (2022). Sulfur [18F]Fluoride Exchange Reaction Enables Rapid Access to 18F-Labeled PET Tracers. SHILAP Revista de lepidopterología. 127–127. 1 indexed citations
12.
Kopka, Klaus, et al.. (2022). Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis. Pharmaceuticals. 15(6). 747–747. 29 indexed citations
13.
Stadlbauer, Sven, Mareike Roscher, Wael Khoder, et al.. (2021). The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 2057–2058. 27 indexed citations
14.
Laube, Markus, et al.. (2021). Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents. Pharmaceuticals. 14(11). 1155–1155. 5 indexed citations
15.
Bauder‐Wüst, Ulrike, Martin Schäfer, Jana Schmidt, et al.. (2019). Designing tracers for PET imaging of the urokinase‐type plasminogen activator receptor from a cyclic uPA‐derived peptide: first in vitro evaluations. Journal of Labelled Compounds and Radiopharmaceuticals. 62(8). 483–494. 1 indexed citations
16.
17.
Stadlbauer, Sven, et al.. (2012). Imitation and modification of bioactive lead structures via integration of boron clusters. Pure and Applied Chemistry. 84(11). 2289–2298. 8 indexed citations
18.
Frank, René, et al.. (2011). Incorporation ofortho-Carbaboranyl-Nε-Modifiedl-Lysine into Neuropeptide Y Receptor Y1- and Y2-Selective Analogues. Journal of Medicinal Chemistry. 54(7). 2368–2377. 60 indexed citations
19.
Stadlbauer, Sven, et al.. (2009). Synthesis and Reactivity of ortho-Carbaborane-Containing Chiral Aminohalophosphines. Inorganic Chemistry. 48(13). 6072–6082. 29 indexed citations
20.
Stadlbauer, Sven, Peter Lönnecke, Peter Welzel, & Evamarie Hey‐Hawkins. (2009). Highly Water‐Soluble Carbaborane‐Bridged Bis(glycophosphonates). European Journal of Organic Chemistry. 2009(36). 6301–6310. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026